ZURA: zurabio.com Kompaniya qiymatining sof foydaga nisbati
Zura Bio Limited (ZURA) og'ir yallig'lanish jarayonlarini davolash uchun antitanalarni ishlab chiqadi va diversifikatsiyalashgan loyihalar portfeli (dermatit, alopesiya) orqali risklarni kamaytiradi. Ushbu narxlar grafigi -1.00 miqdoridagi PE koeffitsiyentini aks ettiradi. Kompaniya ilg'or tadqiqotlar va bonuslar imkoniyatini taqdim etish orqali yetakchi immunologlarni jalb qilmoqda. Biznes hozirda foyda olishdan oldingi bosqichda bo'lib, bunda sezilarli R&D xarajatlari doimiy xarajatlarning yuqori bazasini shakllantiradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_ZURA_-_Zura-Bio-Limited_-_PE-Multiple "ZURA: Zura Bio Limited Biznesning o‘zini qoplash muddati 28.04.2023 - 14.11.2026 | 👁️GURU.Markets👁️")
Zura Bio Limited (ZURA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati zurabio.com|ZURA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Zura Bio Limited|ZURA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Zura Bio|Kritik likvidlik koeffitsiyenti zurabio.com
- foyda va bozor multiplikatorlari tafsilotlari:
ZURA - Sof daromad|Prognoz qilingan kelajakdagi foyda Zura Bio Limited|ZURA - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Zura Bio Ltd|ZURA - PEG multiplikatori|EV/EBITDA multiplikatori Zura Bio Limited|ZURA - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Zura Bio|ZURA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi zurabio.com|ZURA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Zura Bio Limited
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Zura Bio Ltd ZURA
Investorlar ushbu koeffitsiyentdan biznesning sof foydasining bir birligi uchun to'langan premiumni aniqlash uchun foydalanadilar. Ushbu metrika aksiyaning joriy bozor narxini aksiyaga to'g'ri keladigan yillik foydaga bo'lish orqali hisoblanadi. Zura Bio Limited (ZURA) uchun makrotsikllardan mustaqillik va innovatsiyalarga bo'lgan talab ushbu hisob-kitobni aktivning himoya xususiyatlari ko'rsatkichi qiladi. Kompaniyaning joriy bozor P/E koeffitsiyenti narxlar dinamikasi biznes baholashining fundamental foydaga nisbatan muvozanatini baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati TRML|PGEN (Precigen, Inc.) - Narx-foyda koeffitsiyenti|pharming.com (PHAR) - P/E multiplikatori|Narxning foydaga nisbati Nektar Therapeutics Inc.|UPB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati KALV|Septerna - P/E multiplikatori|PVLA: Narxning foydaga nisbati|SVRA: P/E multiplikatori|RIGL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati AnaptysBio, Inc.|Kapitalizatsiyaning foydaga nisbati astriatx.com ATXS|Narx-foyda koeffitsiyenti ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc - Narxning foydaga nisbati|Kyverna Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati tizianalifesciences.com TLSA|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|THTX (Theratechnologies Inc) - P/E multiplikatori|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|Bozor narxining sof foydaga nisbati AGEN|P/E multiplikatori CLYM (Climb Bio)|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning foydaga nisbati|Adagene Corp - P/E multiplikatori|IMA (ImageneBio Inc) - Narx-foyda multiplikatori|STTK (shattucklabs.com) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati EQ (Equillium)|Narx-foyda koeffitsiyenti CNTB|P/E multiplikatori Immunic Inc|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|CELU - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati INMB|BRNS: P/E multiplikatori|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|SABS (SAB Biotherapeutics) - P/E multiplikatori|P/E multiplikatori akaritx.com|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA - Narx-foyda koeffitsiyenti|iBio, Inc. - P/E multiplikatori|CARM - P/E multiplikatori|XTLB (XTL Biopharmaceuticals Ltd.) - Narx-foyda koeffitsiyenti|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Aptevo (APVO) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|Narxning foydaga nisbati GRI Bio GRI|XRTX - Narx-foyda koeffitsiyenti|HIND: Narx-foyda koeffitsiyenti|REVB - P/E multiplikatori|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda multiplikatori SCNI|CALI (CalciMedica Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Affimed Therapeutics AFMD|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|HOOK: Kapitalizatsiyaning sof foydaga nisbati|IGM Biosciences - Narx-foyda koeffitsiyenti|P/E multiplikatori iteostherapeutics.com ITOS|OCEA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD: P/E multiplikatori
